 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Enrollment change, Trial completion date, Trial termination, CAR T-Cell Therapy, Metastases: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov) - Aug 9, 2024
P1, N=10, Terminated, Sponsor: jianming xu
N=34 --> 10 | Trial completion date: Oct 2026 --> Jul 2024 | Recruiting --> Terminated; achieve the proof of concept
- || Enrollment open, CAR T-Cell Therapy, Metastases: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov) - Jun 14, 2022
P1, N=34, Recruiting, Sponsor: jianming xu
N=34 --> 10 | Trial completion date: Oct 2026 --> Jul 2024 | Recruiting --> Terminated; achieve the proof of concept Not yet recruiting --> Recruiting
- || New P1 trial, CAR T-Cell Therapy, Metastases: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma (clinicaltrials.gov) - Apr 28, 2022
P1, N=34, Not yet recruiting, Sponsor: jianming xu